New! Sign up for our free email newsletter.
Science News
from research organizations

Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria

Date:
February 7, 2018
Source:
Wiley
Summary:
A new study indicates that the drug fosfomycin may be effective for treating multidrug-resistant bacterial infections. In most European countries, the oral formulation is only approved as a 3 gram single dose for the treatment of uncomplicated cystitis; however a new study found that a dosing regimen of 6-12 grams per day divided in 3 doses is required for the treatment of systemic multi-drug-resistant bacterial infections.
Share:
FULL STORY

A new study indicates that the drug fosfomycin may be effective for treating multidrug-resistant bacterial infections.

In most European countries, the oral formulation is only approved as a 3 gram single dose for the treatment of uncomplicated cystitis; however the Pharmacology Research & Perspectives study found that a dosing regimen of 6-12 grams per day divided in 3 doses is required for the treatment of systemic multi-drug-resistant bacterial infections.

Fosfomycin -- an 'old' antibiotic that was developed more than 40 years ago -- is a broad spectrum antibiotic that inhibits the early stages of the bacterial cell wall synthesis.

"Importantly, we show that there is a viable alternative to the lengthy and thus costly development of new antibiotics. The often scattered knowledge in literature and in the clinic is waiting to be combined and can be used immediately in a confirmatory clinical trial," said senior author Dr. Jasper Stevens, of the University Medical Center Groningen, in The Netherlands.


Story Source:

Materials provided by Wiley. Note: Content may be edited for style and length.


Journal Reference:

  1. Natalia V. Ortiz Zacarías, Anneke C. Dijkmans, Jacobus Burggraaf, Johan W. Mouton, Erik B. Wilms, Cees van Nieuwkoop, Daan J. Touw, Ingrid M. C. Kamerling, Jasper Stevens. Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens. Pharmacology Research & Perspectives, 2018; 6 (1): e00378 DOI: 10.1002/prp2.378

Cite This Page:

Wiley. "Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria." ScienceDaily. ScienceDaily, 7 February 2018. <www.sciencedaily.com/releases/2018/02/180207090059.htm>.
Wiley. (2018, February 7). Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria. ScienceDaily. Retrieved November 6, 2024 from www.sciencedaily.com/releases/2018/02/180207090059.htm
Wiley. "Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria." ScienceDaily. www.sciencedaily.com/releases/2018/02/180207090059.htm (accessed November 6, 2024).

Explore More

from ScienceDaily

RELATED STORIES